Abstract
Engagement of the Granulocyte-Colony-Stimulating Factor (G-CSF) receptor activates non-receptor protein tyrosine kinases Lyn and Jak2. We found that Lyn-deficient DT40 cells that express the G-CSF receptor (DT40GR) do not demonstrate G-CSF-induced mitogenic signaling. Lyn associates with and phosphorylates a small set of molecules, including c-Cbl. c-Cbl is an adaptor involved in cell growth and cytoskeletal reorganization, predominantly in hematopoietic cells. Using yeast two-hybrid analysis, we found that c-Cbl directly couples Lyn to PI 3-kinase. We also found that expression of the c-CblY731F mutant, which uncouples PI 3-kinase, resulted in the inhibition of G-CSF-induced proliferative signaling in DT40GR cells. As a complementary strategy, we sought to analyse the effects of c-Cbl deficiency in DT40GR cells. We isolated, cloned and sequenced the full-length cDNA for chicken c-Cbl and constructed antisense vectors. Antisense inhibition of c-Cbl expression in DT40GR cells led to enhanced Jak-STAT activation following G-CSF stimulation. Yet, this enhancement of Jak-STAT activation was associated with decreased G-CSF-induced PI 3-kinase activity and DNA synthesis. PI 3-kinase activity correlated with DNA synthesis and physiological levels of c-Cbl. Together, these data suggest that physiologic level of c-Cbl provides a growth stimulatory pathway for G-CSF and that enhanced Jak-STAT activation is not sufficient for G-CSF-induced growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andoniou CE, Lill NL, Thien CB, Lupher Jr ML, Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H . 2000 Mol. Cell. Biol. 20: 851–867
Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H, Choi Y . 2001 J. Biol. Chem. 276: 30011–30017
Avalos BR . 1996 Blood 88: 761–777
Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, Mariathasan S, Bouchard D, Wakeham A, Itie A, Le J, Ohashi PS, Sarosi I, Nishina H, Lipkowitz S, Penninger JM . 2000 Nature 403: 211–216
Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, Jang IK, Gutkind JS, Shevach E, Gu H . 2000 Nature 403: 216–220
Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4683–4687
Corey SJ, Dombrosky-Ferlan PM, Zuo S, Krohn E, Donnenberg AD, Zorich P, Romero G, Takata M, Kurosaki T . 1998 J. Biol. Chem. 273: 3230–3235
de Jong R, ten Hoeve J, Heisterkamp N, Groffen J . 1995 J. Biol. Chem. 270: 21468–21471
Dombrosky-Ferlan PM, Corey SJ . 1997 Oncogene 14: 2019–2024
Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC . 1999 Oncogene 18: 1147–1156
Erdreich-Epstein A, Liu M, Kant AM, Izadi KD, Nolta JA, Durden DL . 1999 J. Leukoc. Biol. 65: 523–534
Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S . 1999 Oncogene 18: 1855–1866
Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC . 2001 J. Biol. Chem. 276: 4872–4878
Felsenstein J . 1995 PHYLIP (Phylogeny Inference Package) Seattle: University of Washington
Finkelstein LD, Shimizu Y . 2000 Biochem. J. 345: Pt 2 385–392
Garcia-Guzman M, Larsen E, Vuori K . 2000 Oncogene 19: 4058–4065
Grishin A, Sinha S, Roginskaya V, Boyer MJ, Gomez-Cambronero J, Zuo S, Kurosaki T, Romero G, Corey SJ . 2000 Oncogene 19: 97–105
Hamilton E, Miller KM, Helm KM, Langdon WY, Anderson SM . 2001 J. Biol. Chem. 276: 9028–9037
Hartley D, Meisner H, Corvera S . 1995 J. Biol. Chem. 270: 18260–18263
Hsueh RC, Scheuermann RH . 2000 Adv. Immunol. 75: 283–316
Ikeda M, Ikeda A, Longan LC, Longnecker R . 2000 Virology 268: 178–191
Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC . 1999 Science 286: 309–312
Kawakami Y, Kitaura J, Satterthwaite AB, Kato RM, Asai K, Hartman SE, Maeda-Yamamoto M, Lowell CA, Rawlings DJ, Witte ON, Kawakami T . 2000 J. Immunol. 165: 1210–1219
Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S . 1999 Oncogene 18: 3365–3375
Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S . 1995 Oncogene 10: 2367–2377
Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T . 1999 Gene 239: 145–154
Lahti JM . 1999 Methods 17: 305–312
Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HCd . 1989 Proc. Natl. Acad. Sci. USA 86: 1168–1172
Liu YC, Altman A . 1998 Cell Signal 10: 377–385
Lupher Jr ML, Rao N, Eck MJ, Band H . 1999 Immunol. Today 20: 375–382
Meng F, Lowell CA . 1998 EMBO J. 17: 4391–4403
Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB, Langdon WY, Bowtell DD . 1998 Mol. Cell. Biol. 18: 4872–4882
Naramura M, Kole HK, Hu RJ, Gu H . 1998 Proc. Natl. Acad. Sci. USA 95: 15547–15552
Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K . 1998 Cell 93: 397–409
Nishizumi H, Horikawa K, Mlinaric-Rascan I, Yamamoto T . 1998 J. Exp. Med. 187: 1343–1348
Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T . 1995 Immunity 3: 549–560
Oda H, Kumar S, Howley PM . 1999 Proc. Natl. Acad. Sci. USA 96: 9557–9562
Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN . 1998 Cell 93: 385–395
Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, Band H . 2002 Proc. Natl. Acad. Sci. USA 99: 3794–3799
Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson Jr EM, Schreiber RD . 1998 Cell 93: 373–383
Saci A, Rendu F, Bachelot-Loza C . 2000 Biochem. J. 351: Pt 3 669–676
Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW, Witte ON . 1998 J. Exp. Med. 188: 833–844
Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD . 1997 J. Biol. Chem. 272: 10248–10253
Scholz G, Cartledge K, Dunn AR . 2000 J. Biol. Chem. 275: 14615–14623
Sinha S, Jancarik J, Roginskaya V, Rothermund K, Boxer LM, Corey SJ . 2001 Exp. Hematol. 29: 746–755
Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H, Kurosaki T . 1994 EMBO J. 13: 1341–1349
Tezuka T, Umemori H, Fusaki N, Yagi T, Takata M, Kurosaki T, Yamamoto T . 1996 J. Exp. Med. 183: 675–680
Thien CB, Walker F, Langdon WY . 2001 Mol. Cell 7: 355–365
Thompson JD, Higgins DG, Gibson TJ . 1994 Nucleic Acids Res. 22: 4673–4680
Ueno H, Sasaki K, Honda H, Nakamoto T, Yamagata T, Miyagawa K, Mitani K, Yazaki Y, Hirai H . 1998 Blood 91: 46–53
Ueno H, Sasaki K, Miyagawa K, Honda H, Mitani K, Yazaki Y, Hirai H . 1997 J. Biol. Chem. 272: 8739–8743
Willeke T, Behrens S, Scharffetter-Kochanek K, Gaehtgens P, Walzog B . 2000 J. Leukoc. Biol. 68: 284–292
Yasuda T, Maeda A, Kurosaki M, Tezuka T, Hironaka K, Yamamoto T, Kurosaki T . 2000 J. Exp. Med. 191: 641–650
Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, Baron R . 2001 J. Biol. Chem. 276: 35185–35193
Zheng N, Wang P, Jeffrey PD, Pavletich NP . 2000 Cell 102: 533–539
Author information
Authors and Affiliations
Corresponding author
Additional information
The full-length nucleotide sequence of the chicken c-Cbl cDNA has been registered as GenBank accession number AF318895.
Rights and permissions
About this article
Cite this article
Wang, L., Rudert, W., Loutaev, I. et al. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene 21, 5346–5355 (2002). https://doi.org/10.1038/sj.onc.1205670
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205670
Keywords
This article is cited by
-
Overexpression of E3 ubiquitin ligase Cbl attenuates endothelial dysfunction in diabetes mellitus by inhibiting the JAK2/STAT4 signaling and Runx3-mediated H3K4me3
Journal of Translational Medicine (2021)
-
B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3
Leukemia (2019)
-
Time resolved quantitative phospho-tyrosine analysis reveals Bruton’s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors
Leukemia (2019)